论文部分内容阅读
本文通过对诺衡与多烯康分别治疗25例和27例高脂血症或低高密度脂蛋白血症患者进行血脂和血小板聚集的观察,结果发现这两种调脂药对胆固醇(ch)影响依治疗前 ch 高低不同呈现降低或升高的双相反应;对高密度脂蛋白胆固醇(HDL—C)、HDL—C/ch 两药均呈调高反应;两药均对血小板聚集率有明显降低作用;以上各项组间无显著差异。提示两药均为抗动脉粥样硬化的理想药物。
In this paper, we observed the blood lipid and platelet aggregation in 25 cases and 27 cases of hyperlipidemia or low-density lipoproteinemia patients treated with Noble and Docetaxel. The results showed that these two kinds of lipid- The effect of pre-treatment according to the different ch of low or high biphasic response; for high-density lipoprotein cholesterol (HDL-C), HDL-C / ch two drugs showed an increase in response to both drugs are associated with platelet aggregation rate Significantly reduce the effect; no significant difference between the above groups. Tip two drugs are the ideal anti-atherosclerotic drugs.